ProQR Therapeutics N.V. filed a Form 6-K on May 4, 2026, announcing its 2026 Annual General Meeting of Shareholders to be held on June 2, 2026, with proposals including board changes and capital increase.
Key takeaways
AGM scheduled for June 2, 2026, with record date May 5, 2026.
Proposal to appoint Dr. Lykke Hinsch Gylvin as non-executive director for 4-year term.
Proposal to increase authorized share capital to 270 million ordinary and 270 million preferred shares.
Proposal to authorize board to issue up to 100% of authorized capital for 5 years.
Proposal to authorize board to repurchase up to 10% (plus additional 10% in reorganization) of issued shares.
Dinko Valerio and Alison Lawton to retire from the board.